Navigation Links
GFX: Wrinkle-Killer or Botox(R) Hit-Man?

NORTH DALLAS, Texas and PLANO, Texas, March 10 /PRNewswire/ -- Tired of frequent Botox injection visits? GFX might be the long-term wrinkle solution for you!

Newly-FDA approved GFX (Glabella Furrow Relaxation) recently arrived in North Texas and is already making waves -- radiofrequency waves, to be exact -- in select aesthetic centers and cosmetic surgery offices. GFX is a unique technological advancement in facial rejuvenation that offers long-term relaxation of overactive 'frown' muscles; a proposition likely to thrill many long-time Botox users, but one that targets the Botox(R) empire for a kill-shot where it would hurt the most ... right between the eyebrows.

Botox(R) muscle-relaxing injection results typically last from 3 to 4 months on average, while the results of one in-office GFX (sometimes called 'No-tox') treatment averages 18 months or longer. According to Jeffrey Adelglass, M.D., F.A.C.S., a popular North Dallas area cosmetic surgeon who has had plenty of experience working with a variety of cosmetic injectables, treatment of the glabella area alone constitutes approximately 65% -- the lion's share -- of his Botox injections. While his GFX patients might still receive periodic Botox(R) injections in other forehead areas (GFX is currently only FDA-approved for the glabella), sometimes keeping the glabella relaxed can, over time, soften wrinkles in other forehead areas, as well. An observed effect of the treatment has been that eyebrows gradually tend to become more elevated and horizontal forehead lines reduced, potentially eliminating the need for elective surgery or neurotoxin injections entirely for some aesthetic patients.

How does GFX work? This minimally-invasive, in-office procedure utilizes a specified dose of radiofrequency (RF) thermal energy, delivered through an insulated bipolar needle inserted near the eyebrows, on either side of the forehead. First, the doctor delivers a stimulating pulse through the needle tome and recovery.


Pamela Fox, Director of Communications, 972-620-3223

SOURCE SKINTASTIC Medical and Surgical Rejuvenation Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AAFPRS Speaks to the Safety of BOTOX(R) Cosmetic
2. American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox(R) Products
Post Your Comments:
(Date:11/28/2015)... PA (PRWEB) , ... November 28, 2015 , ... Safe ... the creativity of two inventors, one from Lakewood, New Jersey and the other from ... developed the patent-pending PROTECTOR to save the expense of having to replace NuvaRings more ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... meeting in Washington D.C. revolved around the fact that proper dental care, both at-home ... stressed the link between periodontal disease (more commonly referred to as gum disease) and ...
(Date:11/27/2015)... ... November 27, 2015 , ... An ... way to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC ... and dispense prescription medications. In doing so, it could help to prevent potential ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... innovative online platform for mental health and wellness consultation, has collaborated with a ... will bridge the knowledge gap experienced by parents and bring advice from parenting ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
Breaking Medicine Technology: